

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.49008581 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.48986425 |
| 3 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.29101468 |
| 4 | regulation of neuronal synaptic plasticity (GO:0048168) | 5.23361672 |
| 5 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.16228491 |
| 6 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.11352489 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.09042685 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.98378811 |
| 9 | synaptic vesicle maturation (GO:0016188) | 4.95942563 |
| 10 | long-term synaptic potentiation (GO:0060291) | 4.95200542 |
| 11 | glutamate secretion (GO:0014047) | 4.88916887 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.75308958 |
| 13 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.73026597 |
| 14 | positive regulation of synapse maturation (GO:0090129) | 4.69299558 |
| 15 | glutamate receptor signaling pathway (GO:0007215) | 4.61205336 |
| 16 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.61154318 |
| 17 | response to corticosterone (GO:0051412) | 4.59119586 |
| 18 | protein localization to synapse (GO:0035418) | 4.54020162 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.47936295 |
| 20 | neuron recognition (GO:0008038) | 4.33524450 |
| 21 | serotonin metabolic process (GO:0042428) | 4.32966121 |
| 22 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.22313925 |
| 23 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 4.14052063 |
| 24 | cerebellar granule cell differentiation (GO:0021707) | 4.12057060 |
| 25 | regulation of synaptic plasticity (GO:0048167) | 4.10043913 |
| 26 | locomotory exploration behavior (GO:0035641) | 4.03717612 |
| 27 | synaptic transmission, glutamatergic (GO:0035249) | 4.00151163 |
| 28 | response to gravity (GO:0009629) | 3.99443924 |
| 29 | vocalization behavior (GO:0071625) | 3.96877228 |
| 30 | response to mineralocorticoid (GO:0051385) | 3.93468601 |
| 31 | regulation of synaptic vesicle transport (GO:1902803) | 3.93429808 |
| 32 | positive regulation of membrane potential (GO:0045838) | 3.93278572 |
| 33 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.92039193 |
| 34 | positive regulation of dendritic spine development (GO:0060999) | 3.91521726 |
| 35 | behavioral defense response (GO:0002209) | 3.89006868 |
| 36 | behavioral fear response (GO:0001662) | 3.89006868 |
| 37 | primary amino compound metabolic process (GO:1901160) | 3.87614980 |
| 38 | sleep (GO:0030431) | 3.87118437 |
| 39 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.86065553 |
| 40 | long term synaptic depression (GO:0060292) | 3.83893283 |
| 41 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.83737370 |
| 42 | signal complex assembly (GO:0007172) | 3.81983721 |
| 43 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.77984200 |
| 44 | neuron-neuron synaptic transmission (GO:0007270) | 3.73738525 |
| 45 | neuron cell-cell adhesion (GO:0007158) | 3.70542694 |
| 46 | fear response (GO:0042596) | 3.70472993 |
| 47 | exploration behavior (GO:0035640) | 3.69131260 |
| 48 | neuronal action potential propagation (GO:0019227) | 3.66019171 |
| 49 | response to pheromone (GO:0019236) | 3.66018427 |
| 50 | regulation of synapse maturation (GO:0090128) | 3.65243612 |
| 51 | regulation of synapse structural plasticity (GO:0051823) | 3.64471644 |
| 52 | axonal fasciculation (GO:0007413) | 3.62108948 |
| 53 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.57172507 |
| 54 | glycerophospholipid catabolic process (GO:0046475) | 3.54180677 |
| 55 | regulation of postsynaptic membrane potential (GO:0060078) | 3.54114452 |
| 56 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.50504821 |
| 57 | cellular response to gonadotropin stimulus (GO:0071371) | 3.44797028 |
| 58 | long-term memory (GO:0007616) | 3.42355512 |
| 59 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.40605237 |
| 60 | regulation of glutamate secretion (GO:0014048) | 3.40577954 |
| 61 | cellular sodium ion homeostasis (GO:0006883) | 3.39110028 |
| 62 | regulation of dendritic spine development (GO:0060998) | 3.38166181 |
| 63 | activation of Rac GTPase activity (GO:0032863) | 3.36105751 |
| 64 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.32613680 |
| 65 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.31037978 |
| 66 | alanine transport (GO:0032328) | 3.30241978 |
| 67 | regulation of vesicle fusion (GO:0031338) | 3.29986812 |
| 68 | neurotransmitter secretion (GO:0007269) | 3.29139068 |
| 69 | presynaptic membrane assembly (GO:0097105) | 3.28844105 |
| 70 | response to histamine (GO:0034776) | 3.26873228 |
| 71 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.26070178 |
| 72 | gamma-aminobutyric acid transport (GO:0015812) | 3.25085083 |
| 73 | synaptic vesicle endocytosis (GO:0048488) | 3.24376871 |
| 74 | layer formation in cerebral cortex (GO:0021819) | 3.21207285 |
| 75 | detection of calcium ion (GO:0005513) | 3.19984948 |
| 76 | protein localization to cilium (GO:0061512) | 3.18078242 |
| 77 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.17924173 |
| 78 | clathrin coat assembly (GO:0048268) | 3.17318842 |
| 79 | neurotransmitter transport (GO:0006836) | 3.17058637 |
| 80 | insulin secretion (GO:0030073) | 3.15518896 |
| 81 | regulation of sarcomere organization (GO:0060297) | 3.15285270 |
| 82 | innervation (GO:0060384) | 3.14635969 |
| 83 | positive regulation of fibroblast migration (GO:0010763) | 3.14063786 |
| 84 | learning (GO:0007612) | 3.13908760 |
| 85 | dendrite morphogenesis (GO:0048813) | 3.13784695 |
| 86 | regulation of glucocorticoid secretion (GO:2000849) | 3.13689587 |
| 87 | dopamine receptor signaling pathway (GO:0007212) | 3.12519116 |
| 88 | presynaptic membrane organization (GO:0097090) | 3.12141324 |
| 89 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.11775690 |
| 90 | regulation of bile acid biosynthetic process (GO:0070857) | 3.11509005 |
| 91 | postsynaptic membrane organization (GO:0001941) | 3.07538967 |
| 92 | response to isoquinoline alkaloid (GO:0014072) | 3.06140110 |
| 93 | dendritic spine morphogenesis (GO:0060997) | 3.05809460 |
| 94 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.05614829 |
| 95 | chemosensory behavior (GO:0007635) | 3.05109567 |
| 96 | membrane depolarization (GO:0051899) | 3.04547531 |
| 97 | dendritic spine organization (GO:0097061) | 3.02437069 |
| 98 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.00478409 |
| 99 | associative learning (GO:0008306) | 3.00442331 |
| 100 | positive regulation of synaptic transmission (GO:0050806) | 2.97940473 |
| 101 | membrane depolarization during action potential (GO:0086010) | 2.96653740 |
| 102 | cellular response to calcium ion (GO:0071277) | 2.96361751 |
| 103 | regulation of synaptic transmission (GO:0050804) | 2.95427810 |
| 104 | response to amphetamine (GO:0001975) | 2.94667452 |
| 105 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.92584792 |
| 106 | neuromuscular process controlling balance (GO:0050885) | 2.90971767 |
| 107 | glial cell proliferation (GO:0014009) | 2.90536372 |
| 108 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.90206951 |
| 109 | regulation of neurotransmitter levels (GO:0001505) | 2.90002305 |
| 110 | negative regulation of dendrite development (GO:2000171) | 2.89289499 |
| 111 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.88686435 |
| 112 | nucleobase catabolic process (GO:0046113) | 2.88672664 |
| 113 | negative regulation of amino acid transport (GO:0051956) | 2.88296626 |
| 114 | relaxation of smooth muscle (GO:0044557) | 2.87688865 |
| 115 | proline transport (GO:0015824) | 2.87571899 |
| 116 | cerebellar Purkinje cell layer development (GO:0021680) | 2.87500590 |
| 117 | learning or memory (GO:0007611) | 2.86636517 |
| 118 | regulation of neurotransmitter transport (GO:0051588) | 2.85600718 |
| 119 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.85470884 |
| 120 | negative regulation of circadian rhythm (GO:0042754) | 2.84449097 |
| 121 | positive regulation of neurotransmitter transport (GO:0051590) | 2.83714713 |
| 122 | cellular potassium ion homeostasis (GO:0030007) | 2.83100174 |
| 123 | dentate gyrus development (GO:0021542) | 2.82609382 |
| 124 | startle response (GO:0001964) | 2.81659872 |
| 125 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.80624752 |
| 126 | positive regulation of meiosis (GO:0045836) | 2.80367923 |
| 127 | regulation of neurotransmitter uptake (GO:0051580) | 2.79086026 |
| 128 | response to dietary excess (GO:0002021) | 2.77656829 |
| 129 | urinary tract smooth muscle contraction (GO:0014848) | 2.75822646 |
| 130 | negative regulation of neurotransmitter transport (GO:0051589) | 2.75290604 |
| 131 | glycosphingolipid biosynthetic process (GO:0006688) | 2.73477498 |
| 132 | synaptic transmission (GO:0007268) | 2.69884970 |
| 133 | neuron fate determination (GO:0048664) | 2.69650549 |
| 134 | neuronal ion channel clustering (GO:0045161) | 2.68627044 |
| 135 | righting reflex (GO:0060013) | 2.65930523 |
| 136 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.65438307 |
| 137 | potassium ion transmembrane transport (GO:0071805) | 2.65283099 |
| 138 | cellular potassium ion transport (GO:0071804) | 2.65283099 |
| 139 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.62431441 |
| 140 | macroautophagy (GO:0016236) | 2.61199295 |
| 141 | calcium ion-dependent exocytosis (GO:0017156) | 2.60413834 |
| 142 | potassium ion homeostasis (GO:0055075) | 2.59585442 |
| 143 | signal release (GO:0023061) | 2.58960555 |
| 144 | positive regulation of meiotic cell cycle (GO:0051446) | 2.57373464 |
| 145 | indole-containing compound metabolic process (GO:0042430) | 2.56238885 |
| 146 | calcium ion import (GO:0070509) | 2.55827388 |
| 147 | regulation of neurotransmitter secretion (GO:0046928) | 2.55111454 |
| 148 | epithelial cell fate commitment (GO:0072148) | 2.54386141 |
| 149 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.52578743 |
| 150 | neurofilament cytoskeleton organization (GO:0060052) | 2.52368310 |
| 151 | brain morphogenesis (GO:0048854) | 2.52228881 |
| 152 | response to cocaine (GO:0042220) | 2.50397049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.54199211 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.56905965 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.25263328 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11218090 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.06120714 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.89575988 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.89575988 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.88560385 |
| 9 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.83921834 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.82923782 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.75999138 |
| 12 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.72758384 |
| 13 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.66535003 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.62313450 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.59018462 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.58363582 |
| 17 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.48213735 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.41664516 |
| 19 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.33721507 |
| 20 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.27704416 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15857469 |
| 22 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13602568 |
| 23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.11398141 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.07964411 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.02197486 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.00777181 |
| 27 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.99154474 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88116060 |
| 29 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.83870765 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.83712839 |
| 31 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.78295954 |
| 32 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.77369162 |
| 33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.77149212 |
| 34 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.73558427 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.69568421 |
| 36 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.63111007 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57101513 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50146330 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.44355772 |
| 40 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.42067306 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.41938834 |
| 42 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.41506910 |
| 43 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.40178707 |
| 44 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.39451836 |
| 45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38424437 |
| 46 | FUS_26573619_Chip-Seq_HEK293_Human | 1.38146137 |
| 47 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36820928 |
| 48 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.36284265 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32344084 |
| 50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.31667776 |
| 51 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31492234 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30192334 |
| 53 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.30154723 |
| 54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30154247 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28964216 |
| 56 | TCF4_23295773_ChIP-Seq_U87_Human | 1.26662353 |
| 57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.26074593 |
| 58 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.24914023 |
| 59 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.24888902 |
| 60 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.22677746 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.20319010 |
| 62 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.17337304 |
| 63 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.16938641 |
| 64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16757815 |
| 65 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.16739625 |
| 66 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16481776 |
| 67 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15663771 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15076959 |
| 69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14345730 |
| 70 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14143388 |
| 71 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.14143388 |
| 72 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14014927 |
| 73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.13504097 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12930931 |
| 75 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11232632 |
| 76 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11225506 |
| 77 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10012677 |
| 78 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09107979 |
| 79 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07537780 |
| 80 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07100741 |
| 81 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06125362 |
| 82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05731356 |
| 83 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.05564002 |
| 84 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05556260 |
| 85 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05217922 |
| 86 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05015911 |
| 87 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04040715 |
| 88 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03002661 |
| 89 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.02407973 |
| 90 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.02267394 |
| 91 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01357919 |
| 92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01111480 |
| 93 | AR_19668381_ChIP-Seq_PC3_Human | 1.01014399 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00440470 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.97755587 |
| 96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97707148 |
| 97 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.97543720 |
| 98 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97417675 |
| 99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96929179 |
| 100 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94872451 |
| 101 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94700336 |
| 102 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.93918930 |
| 103 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.93688268 |
| 104 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93288693 |
| 105 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92572074 |
| 106 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.92483376 |
| 107 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92360789 |
| 108 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91585852 |
| 109 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.90258703 |
| 110 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.90239049 |
| 111 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.89826375 |
| 112 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89169460 |
| 113 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87882383 |
| 114 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87720571 |
| 115 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87625209 |
| 116 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87545858 |
| 117 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.86169897 |
| 118 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84753077 |
| 119 | JUN_21703547_ChIP-Seq_K562_Human | 0.84173714 |
| 120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82440249 |
| 121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.82284018 |
| 122 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80981242 |
| 123 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.79660304 |
| 124 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.79230961 |
| 125 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.79198118 |
| 126 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.78756305 |
| 127 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.78221617 |
| 128 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78221617 |
| 129 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.77075611 |
| 130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76221464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.99043240 |
| 2 | MP0003880_abnormal_central_pattern | 5.72049474 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.22838162 |
| 4 | MP0001501_abnormal_sleep_pattern | 3.57391531 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.36993830 |
| 6 | MP0002638_abnormal_pupillary_reflex | 3.26097157 |
| 7 | MP0009745_abnormal_behavioral_response | 3.13001325 |
| 8 | MP0004270_analgesia | 2.97302626 |
| 9 | * MP0002064_seizures | 2.93525754 |
| 10 | * MP0002572_abnormal_emotion/affect_behav | 2.80263905 |
| 11 | MP0003329_amyloid_beta_deposits | 2.73594107 |
| 12 | MP0005646_abnormal_pituitary_gland | 2.65713688 |
| 13 | MP0003122_maternal_imprinting | 2.52411803 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.40021232 |
| 15 | MP0002272_abnormal_nervous_system | 2.38336668 |
| 16 | * MP0009046_muscle_twitch | 2.28017069 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.27368520 |
| 18 | MP0001486_abnormal_startle_reflex | 2.19262960 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.14775693 |
| 20 | MP0002557_abnormal_social/conspecific_i | 2.09967029 |
| 21 | MP0002736_abnormal_nociception_after | 1.99540237 |
| 22 | MP0003787_abnormal_imprinting | 1.94876204 |
| 23 | MP0002735_abnormal_chemical_nociception | 1.85828402 |
| 24 | MP0002822_catalepsy | 1.82806197 |
| 25 | MP0010368_abnormal_lymphatic_system | 1.77620562 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 1.72569673 |
| 27 | MP0000778_abnormal_nervous_system | 1.70326075 |
| 28 | MP0003890_abnormal_embryonic-extraembry | 1.66663896 |
| 29 | MP0002734_abnormal_mechanical_nocicepti | 1.64496075 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.63183071 |
| 31 | MP0006276_abnormal_autonomic_nervous | 1.62832421 |
| 32 | MP0008569_lethality_at_weaning | 1.62689608 |
| 33 | MP0003195_calcinosis | 1.62204471 |
| 34 | MP0005379_endocrine/exocrine_gland_phen | 1.61293418 |
| 35 | MP0002184_abnormal_innervation | 1.58905413 |
| 36 | * MP0005386_behavior/neurological_phenoty | 1.58675184 |
| 37 | * MP0004924_abnormal_behavior | 1.58675184 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.57886900 |
| 39 | MP0002909_abnormal_adrenal_gland | 1.56978854 |
| 40 | MP0001905_abnormal_dopamine_level | 1.54134469 |
| 41 | MP0006072_abnormal_retinal_apoptosis | 1.53142126 |
| 42 | MP0000604_amyloidosis | 1.49460878 |
| 43 | * MP0004811_abnormal_neuron_physiology | 1.44551169 |
| 44 | MP0001944_abnormal_pancreas_morphology | 1.43193289 |
| 45 | MP0009780_abnormal_chondrocyte_physiolo | 1.43111380 |
| 46 | MP0003075_altered_response_to | 1.42456002 |
| 47 | MP0002163_abnormal_gland_morphology | 1.41652935 |
| 48 | MP0001970_abnormal_pain_threshold | 1.39744986 |
| 49 | MP0003123_paternal_imprinting | 1.36795354 |
| 50 | MP0001502_abnormal_circadian_rhythm | 1.32797024 |
| 51 | MP0001984_abnormal_olfaction | 1.28348133 |
| 52 | MP0002693_abnormal_pancreas_physiology | 1.27793074 |
| 53 | MP0004858_abnormal_nervous_system | 1.27770787 |
| 54 | MP0002102_abnormal_ear_morphology | 1.26969927 |
| 55 | * MP0002066_abnormal_motor_capabilities/c | 1.25340613 |
| 56 | * MP0002882_abnormal_neuron_morphology | 1.23568841 |
| 57 | MP0004133_heterotaxia | 1.19614911 |
| 58 | MP0000955_abnormal_spinal_cord | 1.16795702 |
| 59 | MP0004142_abnormal_muscle_tone | 1.15915545 |
| 60 | MP0006292_abnormal_olfactory_placode | 1.12994571 |
| 61 | MP0003690_abnormal_glial_cell | 1.12919047 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.11792164 |
| 63 | MP0001188_hyperpigmentation | 1.08993528 |
| 64 | MP0003879_abnormal_hair_cell | 1.07308571 |
| 65 | MP0010234_abnormal_vibrissa_follicle | 1.05964480 |
| 66 | MP0010329_abnormal_lipoprotein_level | 1.05946849 |
| 67 | MP0003631_nervous_system_phenotype | 1.03572088 |
| 68 | MP0003633_abnormal_nervous_system | 1.03058196 |
| 69 | MP0002152_abnormal_brain_morphology | 1.00506799 |
| 70 | MP0000631_abnormal_neuroendocrine_gland | 1.00145676 |
| 71 | MP0003183_abnormal_peptide_metabolism | 0.99764851 |
| 72 | MP0003121_genomic_imprinting | 0.98482205 |
| 73 | MP0002090_abnormal_vision | 0.97498940 |
| 74 | MP0002069_abnormal_eating/drinking_beha | 0.97012464 |
| 75 | MP0000569_abnormal_digit_pigmentation | 0.96291270 |
| 76 | MP0003632_abnormal_nervous_system | 0.96260516 |
| 77 | MP0002234_abnormal_pharynx_morphology | 0.95355998 |
| 78 | MP0005595_abnormal_vascular_smooth | 0.94623042 |
| 79 | MP0005187_abnormal_penis_morphology | 0.92698240 |
| 80 | MP0008995_early_reproductive_senescence | 0.91085642 |
| 81 | MP0005623_abnormal_meninges_morphology | 0.91002671 |
| 82 | MP0005551_abnormal_eye_electrophysiolog | 0.90874043 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 0.90498449 |
| 84 | MP0008872_abnormal_physiological_respon | 0.87798445 |
| 85 | MP0002254_reproductive_system_inflammat | 0.87422461 |
| 86 | MP0005409_darkened_coat_color | 0.85987843 |
| 87 | MP0000751_myopathy | 0.85566085 |
| 88 | MP0001346_abnormal_lacrimal_gland | 0.84601114 |
| 89 | MP0001485_abnormal_pinna_reflex | 0.81210178 |
| 90 | MP0001963_abnormal_hearing_physiology | 0.81162668 |
| 91 | MP0004885_abnormal_endolymph | 0.79330764 |
| 92 | * MP0003634_abnormal_glial_cell | 0.77227073 |
| 93 | MP0002876_abnormal_thyroid_physiology | 0.76304964 |
| 94 | MP0004145_abnormal_muscle_electrophysio | 0.74588501 |
| 95 | MP0003119_abnormal_digestive_system | 0.74464812 |
| 96 | MP0004085_abnormal_heartbeat | 0.74349683 |
| 97 | MP0004510_myositis | 0.74056201 |
| 98 | MP0003303_peritoneal_inflammation | 0.73559714 |
| 99 | MP0003137_abnormal_impulse_conducting | 0.73013040 |
| 100 | MP0008961_abnormal_basal_metabolism | 0.72928402 |
| 101 | MP0003953_abnormal_hormone_level | 0.72141240 |
| 102 | MP0005448_abnormal_energy_balance | 0.71968354 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.71691054 |
| 104 | MP0000920_abnormal_myelination | 0.71159250 |
| 105 | MP0000013_abnormal_adipose_tissue | 0.71156538 |
| 106 | MP0001529_abnormal_vocalization | 0.70039110 |
| 107 | MP0002837_dystrophic_cardiac_calcinosis | 0.68560933 |
| 108 | * MP0002229_neurodegeneration | 0.67293115 |
| 109 | MP0010386_abnormal_urinary_bladder | 0.66952085 |
| 110 | MP0008874_decreased_physiological_sensi | 0.66840056 |
| 111 | MP0000639_abnormal_adrenal_gland | 0.66266245 |
| 112 | MP0001756_abnormal_urination | 0.66040807 |
| 113 | MP0002752_abnormal_somatic_nervous | 0.63865145 |
| 114 | MP0005084_abnormal_gallbladder_morpholo | 0.62498778 |
| 115 | MP0008877_abnormal_DNA_methylation | 0.60866101 |
| 116 | MP0001664_abnormal_digestion | 0.60149726 |
| 117 | MP0002653_abnormal_ependyma_morphology | 0.58220817 |
| 118 | MP0003283_abnormal_digestive_organ | 0.57204323 |
| 119 | MP0005394_taste/olfaction_phenotype | 0.57097639 |
| 120 | MP0005499_abnormal_olfactory_system | 0.57097639 |
| 121 | MP0004742_abnormal_vestibular_system | 0.56061252 |
| 122 | MP0004147_increased_porphyrin_level | 0.54754032 |
| 123 | MP0001177_atelectasis | 0.52730385 |
| 124 | MP0005535_abnormal_body_temperature | 0.51880489 |
| 125 | MP0005253_abnormal_eye_physiology | 0.51505834 |
| 126 | MP0010770_preweaning_lethality | 0.49277075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.53613931 |
| 2 | Focal seizures (HP:0007359) | 5.45482560 |
| 3 | Myokymia (HP:0002411) | 5.41892321 |
| 4 | Limb dystonia (HP:0002451) | 5.36770086 |
| 5 | Visual hallucinations (HP:0002367) | 5.14722775 |
| 6 | Decreased circulating renin level (HP:0003351) | 5.07073771 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.66963073 |
| 8 | Increased circulating renin level (HP:0000848) | 4.44242256 |
| 9 | Abnormality of the lower motor neuron (HP:0002366) | 4.11899961 |
| 10 | Growth hormone excess (HP:0000845) | 4.03358981 |
| 11 | Hyperactive renin-angiotensin system (HP:0000841) | 4.00601592 |
| 12 | Atonic seizures (HP:0010819) | 3.84771509 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.66229300 |
| 14 | Absence seizures (HP:0002121) | 3.37469477 |
| 15 | Dialeptic seizures (HP:0011146) | 3.31193223 |
| 16 | Action tremor (HP:0002345) | 3.24868032 |
| 17 | Anxiety (HP:0000739) | 3.22143716 |
| 18 | Cerebral inclusion bodies (HP:0100314) | 3.16344016 |
| 19 | Hyperventilation (HP:0002883) | 3.11848905 |
| 20 | Hypothermia (HP:0002045) | 3.11612732 |
| 21 | Abnormal eating behavior (HP:0100738) | 3.11126973 |
| 22 | Hypoglycemic coma (HP:0001325) | 3.03066289 |
| 23 | Generalized tonic-clonic seizures (HP:0002069) | 3.02501526 |
| 24 | Depression (HP:0000716) | 3.00776668 |
| 25 | Hypoglycemic seizures (HP:0002173) | 2.90834555 |
| 26 | Epileptiform EEG discharges (HP:0011182) | 2.88952989 |
| 27 | Febrile seizures (HP:0002373) | 2.88134580 |
| 28 | Agitation (HP:0000713) | 2.84074823 |
| 29 | Progressive cerebellar ataxia (HP:0002073) | 2.79913463 |
| 30 | Excessive salivation (HP:0003781) | 2.79124303 |
| 31 | Drooling (HP:0002307) | 2.79124303 |
| 32 | EEG with generalized epileptiform discharges (HP:0011198) | 2.77432057 |
| 33 | Hyperkalemia (HP:0002153) | 2.76753272 |
| 34 | Poor eye contact (HP:0000817) | 2.75208759 |
| 35 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.71191791 |
| 36 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.70864997 |
| 37 | Broad-based gait (HP:0002136) | 2.70147371 |
| 38 | Hypsarrhythmia (HP:0002521) | 2.69710248 |
| 39 | Papilledema (HP:0001085) | 2.67093175 |
| 40 | Large for gestational age (HP:0001520) | 2.66764334 |
| 41 | Neurofibrillary tangles (HP:0002185) | 2.64919244 |
| 42 | Medial flaring of the eyebrow (HP:0010747) | 2.64090471 |
| 43 | Attenuation of retinal blood vessels (HP:0007843) | 2.55238045 |
| 44 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.52360881 |
| 45 | Abnormality of the labia minora (HP:0012880) | 2.50448055 |
| 46 | Hypomagnesemia (HP:0002917) | 2.48897313 |
| 47 | Rapidly progressive (HP:0003678) | 2.46231307 |
| 48 | Abnormal social behavior (HP:0012433) | 2.46191144 |
| 49 | Impaired social interactions (HP:0000735) | 2.46191144 |
| 50 | Toxemia of pregnancy (HP:0100603) | 2.43546731 |
| 51 | Poor suck (HP:0002033) | 2.43452702 |
| 52 | Ketoacidosis (HP:0001993) | 2.42351161 |
| 53 | Delusions (HP:0000746) | 2.42235324 |
| 54 | Truncal ataxia (HP:0002078) | 2.41849491 |
| 55 | Genetic anticipation (HP:0003743) | 2.41691117 |
| 56 | Abnormality of renin-angiotensin system (HP:0000847) | 2.41576202 |
| 57 | Split foot (HP:0001839) | 2.40971761 |
| 58 | Thickened helices (HP:0000391) | 2.38626531 |
| 59 | Hyperaldosteronism (HP:0000859) | 2.38505576 |
| 60 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.38146528 |
| 61 | Focal dystonia (HP:0004373) | 2.37528169 |
| 62 | Amblyopia (HP:0000646) | 2.36085132 |
| 63 | Failure to thrive in infancy (HP:0001531) | 2.35600770 |
| 64 | Congenital primary aphakia (HP:0007707) | 2.35296742 |
| 65 | Muscular hypotonia of the trunk (HP:0008936) | 2.34425737 |
| 66 | Dysmetria (HP:0001310) | 2.33023320 |
| 67 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.29737611 |
| 68 | Ankle clonus (HP:0011448) | 2.27046093 |
| 69 | Polyphagia (HP:0002591) | 2.25644140 |
| 70 | Hemiparesis (HP:0001269) | 2.24866557 |
| 71 | Akinesia (HP:0002304) | 2.23810384 |
| 72 | Absent speech (HP:0001344) | 2.22917426 |
| 73 | Apathy (HP:0000741) | 2.22598454 |
| 74 | Anteriorly placed anus (HP:0001545) | 2.21001719 |
| 75 | Prominent supraorbital ridges (HP:0000336) | 2.20516214 |
| 76 | Narrow nasal bridge (HP:0000446) | 2.19306390 |
| 77 | Megalencephaly (HP:0001355) | 2.14554896 |
| 78 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.13747306 |
| 79 | Generalized myoclonic seizures (HP:0002123) | 2.13382610 |
| 80 | Gaze-evoked nystagmus (HP:0000640) | 2.12473234 |
| 81 | Sleep apnea (HP:0010535) | 2.11924193 |
| 82 | Abnormality of the corticospinal tract (HP:0002492) | 2.10826445 |
| 83 | Hypoventilation (HP:0002791) | 2.09842873 |
| 84 | Spastic gait (HP:0002064) | 2.09835874 |
| 85 | Unilateral renal agenesis (HP:0000122) | 2.09378788 |
| 86 | Esotropia (HP:0000565) | 2.06805726 |
| 87 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.05923554 |
| 88 | Blue irides (HP:0000635) | 2.05860596 |
| 89 | Hyperthyroidism (HP:0000836) | 2.05026053 |
| 90 | Mesangial abnormality (HP:0001966) | 2.03564278 |
| 91 | Type II lissencephaly (HP:0007260) | 2.03163122 |
| 92 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.02639379 |
| 93 | Progressive inability to walk (HP:0002505) | 2.01618070 |
| 94 | Cerebral hypomyelination (HP:0006808) | 2.01587156 |
| 95 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.00394805 |
| 96 | Spastic tetraplegia (HP:0002510) | 1.99424364 |
| 97 | Peripheral hypomyelination (HP:0007182) | 1.98843324 |
| 98 | Lissencephaly (HP:0001339) | 1.98448268 |
| 99 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.98371553 |
| 100 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.98371553 |
| 101 | Long palpebral fissure (HP:0000637) | 1.98245352 |
| 102 | Intention tremor (HP:0002080) | 1.98232183 |
| 103 | Double outlet right ventricle (HP:0001719) | 1.97921032 |
| 104 | Congenital malformation of the right heart (HP:0011723) | 1.97921032 |
| 105 | Bone cyst (HP:0012062) | 1.96989757 |
| 106 | Nephronophthisis (HP:0000090) | 1.96901012 |
| 107 | Severe muscular hypotonia (HP:0006829) | 1.95175833 |
| 108 | Stereotypic behavior (HP:0000733) | 1.93223130 |
| 109 | Abnormality of magnesium homeostasis (HP:0004921) | 1.92843895 |
| 110 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.92302468 |
| 111 | Open mouth (HP:0000194) | 1.92221121 |
| 112 | Enlarged penis (HP:0000040) | 1.91840808 |
| 113 | Psychosis (HP:0000709) | 1.91660269 |
| 114 | Status epilepticus (HP:0002133) | 1.90780213 |
| 115 | Dysdiadochokinesis (HP:0002075) | 1.90332406 |
| 116 | Late onset (HP:0003584) | 1.88692426 |
| 117 | Obstructive sleep apnea (HP:0002870) | 1.88246233 |
| 118 | Tented upper lip vermilion (HP:0010804) | 1.88231035 |
| 119 | Craniofacial dystonia (HP:0012179) | 1.87224117 |
| 120 | Abnormality of salivation (HP:0100755) | 1.87030846 |
| 121 | Lower limb asymmetry (HP:0100559) | 1.86883288 |
| 122 | Bowel incontinence (HP:0002607) | 1.85578382 |
| 123 | Oligodactyly (hands) (HP:0001180) | 1.85450083 |
| 124 | Insidious onset (HP:0003587) | 1.84666290 |
| 125 | Termporal pattern (HP:0011008) | 1.84666290 |
| 126 | Diminished motivation (HP:0000745) | 1.83699530 |
| 127 | Type I diabetes mellitus (HP:0100651) | 1.83680971 |
| 128 | Hammertoe (HP:0001765) | 1.83372402 |
| 129 | Gait imbalance (HP:0002141) | 1.83358687 |
| 130 | Choroideremia (HP:0001139) | 1.82772246 |
| 131 | Symptomatic seizures (HP:0011145) | 1.82389297 |
| 132 | Large hands (HP:0001176) | 1.81307502 |
| 133 | Conjugated hyperbilirubinemia (HP:0002908) | 1.81027324 |
| 134 | Hyperglycemia (HP:0003074) | 1.80273039 |
| 135 | Polydipsia (HP:0001959) | 1.80092824 |
| 136 | Abnormal drinking behavior (HP:0030082) | 1.80092824 |
| 137 | Abnormality of binocular vision (HP:0011514) | 1.79825435 |
| 138 | Diplopia (HP:0000651) | 1.79825435 |
| 139 | Bradykinesia (HP:0002067) | 1.79275121 |
| 140 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78861681 |
| 141 | Postural tremor (HP:0002174) | 1.77803914 |
| 142 | Unsteady gait (HP:0002317) | 1.77555342 |
| 143 | Torticollis (HP:0000473) | 1.77445474 |
| 144 | Genital tract atresia (HP:0001827) | 1.76256117 |
| 145 | Specific learning disability (HP:0001328) | 1.76098978 |
| 146 | Impaired smooth pursuit (HP:0007772) | 1.75981895 |
| 147 | Diastasis recti (HP:0001540) | 1.75718761 |
| 148 | Abnormality of vitamin B metabolism (HP:0004340) | 1.71593862 |
| 149 | Sensorimotor neuropathy (HP:0007141) | 1.70256271 |
| 150 | Intestinal atresia (HP:0011100) | 1.68627009 |
| 151 | Volvulus (HP:0002580) | 1.68566342 |
| 152 | Hyperphosphatemia (HP:0002905) | 1.66536081 |
| 153 | Limb hypertonia (HP:0002509) | 1.65528056 |
| 154 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.65332427 |
| 155 | Widely spaced teeth (HP:0000687) | 1.65019986 |
| 156 | Decreased muscle mass (HP:0003199) | 1.64993467 |
| 157 | Vaginal atresia (HP:0000148) | 1.64093463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.03662842 |
| 2 | EPHA4 | 4.91175472 |
| 3 | ARAF | 3.72199741 |
| 4 | MAP3K9 | 3.68449826 |
| 5 | FRK | 3.53331165 |
| 6 | MAPK15 | 3.22188855 |
| 7 | MUSK | 3.21600743 |
| 8 | KSR2 | 2.92913303 |
| 9 | FES | 2.90178472 |
| 10 | TNIK | 2.79771109 |
| 11 | MAP2K2 | 2.40164589 |
| 12 | PTK2B | 2.26902689 |
| 13 | MAP3K13 | 2.21756429 |
| 14 | NTRK2 | 2.19819180 |
| 15 | FER | 2.02731777 |
| 16 | CSNK1G3 | 2.02576417 |
| 17 | PAK6 | 1.97871044 |
| 18 | MINK1 | 1.92655729 |
| 19 | KSR1 | 1.89476948 |
| 20 | RAF1 | 1.77099671 |
| 21 | ADRBK2 | 1.73976900 |
| 22 | CSNK1G1 | 1.68191394 |
| 23 | DAPK2 | 1.63136970 |
| 24 | MARK1 | 1.61678100 |
| 25 | FGFR2 | 1.58872141 |
| 26 | CASK | 1.54873794 |
| 27 | RIPK4 | 1.43787556 |
| 28 | MAP3K2 | 1.40708978 |
| 29 | MAPK7 | 1.40111842 |
| 30 | RPS6KA2 | 1.39301082 |
| 31 | INSRR | 1.37048497 |
| 32 | ERBB3 | 1.36053497 |
| 33 | WNK3 | 1.35263084 |
| 34 | MAP4K2 | 1.34074116 |
| 35 | TESK1 | 1.28186930 |
| 36 | CDK5 | 1.22477510 |
| 37 | PAK3 | 1.19343433 |
| 38 | UHMK1 | 1.14733945 |
| 39 | PLK2 | 1.12682693 |
| 40 | CAMK2B | 1.12009769 |
| 41 | MAP2K7 | 1.10318478 |
| 42 | DYRK2 | 1.08325919 |
| 43 | MAP3K4 | 1.07809398 |
| 44 | STK11 | 1.06670886 |
| 45 | CAMK2A | 1.04945345 |
| 46 | CAMK1 | 1.04916695 |
| 47 | SGK2 | 1.01906918 |
| 48 | DAPK1 | 1.01039678 |
| 49 | GRK5 | 0.99028573 |
| 50 | BRAF | 0.98095308 |
| 51 | TAOK1 | 0.96753906 |
| 52 | LIMK1 | 0.94373080 |
| 53 | STK38L | 0.92557047 |
| 54 | PRPF4B | 0.91867998 |
| 55 | MAP3K1 | 0.90719536 |
| 56 | CAMK1G | 0.84989315 |
| 57 | PRKAA1 | 0.84817495 |
| 58 | PRKCG | 0.84554479 |
| 59 | CCNB1 | 0.78941136 |
| 60 | MAPK13 | 0.76911695 |
| 61 | MAP2K1 | 0.76553285 |
| 62 | GRK1 | 0.75578075 |
| 63 | MAP3K11 | 0.74648586 |
| 64 | NTRK1 | 0.73987940 |
| 65 | MAP2K6 | 0.73978154 |
| 66 | CAMK2D | 0.71868521 |
| 67 | WNK4 | 0.71161322 |
| 68 | RPS6KL1 | 0.70747526 |
| 69 | RPS6KC1 | 0.70747526 |
| 70 | SIK2 | 0.69707665 |
| 71 | CDK14 | 0.65267240 |
| 72 | CSNK1D | 0.64195889 |
| 73 | STK16 | 0.61023731 |
| 74 | CSNK1E | 0.61019859 |
| 75 | CDK18 | 0.60856010 |
| 76 | BMPR1B | 0.59835608 |
| 77 | CDK15 | 0.59291133 |
| 78 | MOS | 0.59114177 |
| 79 | MAPK10 | 0.57087816 |
| 80 | PRKD3 | 0.57013026 |
| 81 | CAMKK1 | 0.56500348 |
| 82 | CSNK1A1 | 0.56485384 |
| 83 | MARK2 | 0.54965751 |
| 84 | AKT3 | 0.54466275 |
| 85 | CAMK2G | 0.54389872 |
| 86 | IRAK2 | 0.54118140 |
| 87 | FGR | 0.53276411 |
| 88 | DMPK | 0.53169658 |
| 89 | MAP2K4 | 0.53088902 |
| 90 | RPS6KA6 | 0.52415553 |
| 91 | BMPR2 | 0.51523364 |
| 92 | CDK19 | 0.51109660 |
| 93 | VRK1 | 0.50854427 |
| 94 | PINK1 | 0.50759556 |
| 95 | PNCK | 0.49659122 |
| 96 | MAPK4 | 0.49396127 |
| 97 | CDK11A | 0.47879718 |
| 98 | CSNK1G2 | 0.47764440 |
| 99 | PRKCE | 0.47391915 |
| 100 | PRKACA | 0.47046426 |
| 101 | TYRO3 | 0.45873827 |
| 102 | PHKG2 | 0.44753691 |
| 103 | PHKG1 | 0.44753691 |
| 104 | DYRK1A | 0.43755679 |
| 105 | OXSR1 | 0.43577822 |
| 106 | SGK3 | 0.43022818 |
| 107 | LMTK2 | 0.42377884 |
| 108 | FYN | 0.40903898 |
| 109 | RPS6KA3 | 0.40865166 |
| 110 | PAK2 | 0.39990824 |
| 111 | ADRBK1 | 0.39386761 |
| 112 | PRKCH | 0.38924698 |
| 113 | PDK1 | 0.38438999 |
| 114 | PDPK1 | 0.36788405 |
| 115 | NME1 | 0.35656573 |
| 116 | CAMK4 | 0.34992136 |
| 117 | ICK | 0.34701332 |
| 118 | STK38 | 0.34564530 |
| 119 | ZAK | 0.34356879 |
| 120 | SGK1 | 0.34227349 |
| 121 | TRPM7 | 0.33981052 |
| 122 | MAPK8 | 0.33579120 |
| 123 | GRK6 | 0.33077378 |
| 124 | RPS6KB1 | 0.32648592 |
| 125 | PRKCA | 0.32524375 |
| 126 | GSK3B | 0.32428394 |
| 127 | PRKD1 | 0.32121155 |
| 128 | LATS2 | 0.30008321 |
| 129 | SGK223 | 0.29969680 |
| 130 | SGK494 | 0.29969680 |
| 131 | CSNK1A1L | 0.29658737 |
| 132 | GRK7 | 0.29218331 |
| 133 | PRKCZ | 0.29070747 |
| 134 | HCK | 0.27990645 |
| 135 | PRKG1 | 0.27330311 |
| 136 | MAP3K12 | 0.27321487 |
| 137 | STK24 | 0.27169843 |
| 138 | PRKD2 | 0.27118742 |
| 139 | PRKACB | 0.26157493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.65194622 |
| 2 | Amphetamine addiction_Homo sapiens_hsa05031 | 3.27294638 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 3.15532044 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.10925871 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.85823117 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.75334367 |
| 7 | Circadian rhythm_Homo sapiens_hsa04710 | 2.72164102 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.70945498 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.64974629 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 2.61297349 |
| 11 | Cocaine addiction_Homo sapiens_hsa05030 | 2.36738684 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.28735940 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.28547736 |
| 14 | Morphine addiction_Homo sapiens_hsa05032 | 2.25472352 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 2.00253827 |
| 16 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.97455952 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.96271502 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.94324399 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.89458884 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.87639745 |
| 21 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.86576398 |
| 22 | Taste transduction_Homo sapiens_hsa04742 | 1.71328671 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.68262282 |
| 24 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.67141318 |
| 25 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.66161904 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.62301276 |
| 27 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.62228015 |
| 28 | Protein export_Homo sapiens_hsa03060 | 1.59619924 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.56448771 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.56399723 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.54835108 |
| 32 | Renin secretion_Homo sapiens_hsa04924 | 1.54215133 |
| 33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.50692943 |
| 34 | Prion diseases_Homo sapiens_hsa05020 | 1.38315857 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.37866819 |
| 36 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.35979115 |
| 37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33847699 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31778591 |
| 39 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.27473471 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.26716530 |
| 41 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26429468 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.23169800 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12532808 |
| 44 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12130004 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.10108970 |
| 46 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.07576020 |
| 47 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.05692840 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.05677294 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 1.03940357 |
| 50 | Glioma_Homo sapiens_hsa05214 | 0.99785284 |
| 51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96893045 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.93016415 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.92109356 |
| 54 | Melanogenesis_Homo sapiens_hsa04916 | 0.89164279 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88859644 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88239586 |
| 57 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86854397 |
| 58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.86414036 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85019371 |
| 60 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84213264 |
| 61 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.82594639 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.82541065 |
| 63 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.79802058 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.78911658 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77088543 |
| 66 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76597482 |
| 67 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75716447 |
| 68 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72092674 |
| 69 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68683530 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.65936585 |
| 71 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65522000 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65506536 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65464171 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.64014539 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63805528 |
| 76 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63737228 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62277735 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62248213 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60805489 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60773313 |
| 81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.60118707 |
| 82 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59567105 |
| 83 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57252307 |
| 84 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57054307 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56391719 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55796863 |
| 87 | Alcoholism_Homo sapiens_hsa05034 | 0.54923101 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.54764130 |
| 89 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53733469 |
| 90 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52495263 |
| 91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52234560 |
| 92 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.52170981 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.50959106 |
| 94 | Alzheimers disease_Homo sapiens_hsa05010 | 0.50649150 |
| 95 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.50415235 |
| 96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.48318237 |
| 97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46960368 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46363133 |
| 99 | Phototransduction_Homo sapiens_hsa04744 | 0.45434297 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.45028467 |
| 101 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44616068 |
| 102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42839712 |
| 103 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.41784486 |
| 104 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41675088 |
| 105 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.39341090 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39070710 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39054401 |
| 108 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38717778 |
| 109 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38299333 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.35708544 |
| 111 | Salmonella infection_Homo sapiens_hsa05132 | 0.34115846 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33495905 |
| 113 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.32104091 |
| 114 | Basal transcription factors_Homo sapiens_hsa03022 | 0.31537933 |
| 115 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31463018 |
| 116 | Huntingtons disease_Homo sapiens_hsa05016 | 0.31132202 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31129318 |
| 118 | Tight junction_Homo sapiens_hsa04530 | 0.31118499 |
| 119 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.30303077 |
| 120 | ABC transporters_Homo sapiens_hsa02010 | 0.29191992 |
| 121 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28207159 |
| 122 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.28040141 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26909202 |
| 124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26389444 |
| 125 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.25687558 |
| 126 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.23912017 |
| 127 | Bile secretion_Homo sapiens_hsa04976 | 0.23533684 |
| 128 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.23036625 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.21691068 |
| 130 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21022042 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.19240081 |
| 132 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.13862677 |

